» Authors » J Niloff

J Niloff

Explore the profile of J Niloff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 304
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Burke L, Modell M, Niloff J, Kobelin M, Abu-Jawdeh G, Zelenchuk A
J Low Genit Tract Dis . 2015 May; 3(1):49. PMID: 25950329
No abstract available.
2.
Collins L, Niloff J, Burke L, Abu-Jawdeh G, Wang H
J Reprod Med . 2001 Mar; 46(2):105-9. PMID: 11255808
Objective: Pap smear frequency remains controversial, especially for women with consecutive negative smears. We undertook the current study to ascertain the association of high grade squamous intraepithelial lesions (HSIL) and...
3.
Lu K, Garber J, Cramer D, Welch W, Niloff J, Schrag D, et al.
J Clin Oncol . 2000 Jul; 18(14):2728-32. PMID: 10894872
Purpose: To review the findings at prophylactic oophorectomy of a series of women who presented to a familial breast and ovarian cancer clinic. Materials And Methods: Data from medical charts,...
4.
Tung N, Berkowitz R, Matulonis U, Quartulli M, Seiden M, Kim Y, et al.
Gynecol Oncol . 2000 Apr; 77(2):271-7. PMID: 10785477
Objectives: The goal of this study was to determine the maximally tolerated doses (MTDs) of carboplatin, paclitaxel (Taxol), etoposide, and cyclophosphamide (CTEC) with granulocyte-colony stimulating factor (G-CSF, Filgrastim) support as...
5.
Lu K, Cramer D, Muto M, Li E, Niloff J, Mok S
Obstet Gynecol . 1999 Jan; 93(1):34-7. PMID: 9916952
Objective: To determine the frequency of BRCA1 mutations 185delAG and 5382insC and BRCA2 mutation 6174delT in Jewish women with ovarian cancer and in matched controls in a population-based study. Methods:...
6.
Ottensmeier C, Swanson L, Strobel T, Druker B, Niloff J, Cannistra S
Br J Cancer . 1996 Aug; 74(3):446-52. PMID: 8695362
Previous investigators have noted that certain ovarian cancer cell lines secrete and respond to transforming growth factor-alpha (TGF-alpha), suggesting that endogenous activation of the epidermal growth factor (EGF) receptor through...
7.
Faix J, Niloff J, Tognazzi K, Manseau E, Dvorak H, Brown L
Lab Invest . 1996 Jun; 74(6):1105-15. PMID: 8667614
Angiogenesis is a critical factor in the growth, progression, and metastatic spread of solid tumors. Furthermore, angiogenesis has been correlated with prognosis in patients with ovarian cancer. The pathogenesis of...
8.
McHugh M, West P, Assatly C, Duprat L, Howard L, Niloff J, et al.
J Nurs Adm . 1996 Apr; 26(4):21-7. PMID: 8774468
The authors describe how an interdisciplinary team used skills in communication and collaboration to improve patient care on a busy surgical service. A major goal was to establish and maintain...
9.
Jacobs T, Niloff J, Cannistra S
Gynecol Oncol . 1996 Feb; 60(2):301-7. PMID: 8631556
Purpose: The presence of estrogen receptor (ER) and its therapeutic significance in ovarian borderline tumors (OBT) have not been established. We recently observed a response to tamoxifen therapy given empirically...
10.
Cannistra S, Abu-Jawdeh G, Niloff J, Strobel T, Swanson L, Andersen J, et al.
J Clin Oncol . 1995 Aug; 13(8):1912-21. PMID: 7543560
Purpose: CD44 is a hyaluronic acid receptor that exists as a standard 90-kd form (CD44S) as well as several CD44 variant isoforms produced through alternative splicing. Expression of CD44 variants...